Medicus Pharma (MDCX) Equity Ratio (2023 - 2025)

Medicus Pharma (MDCX) has reported Equity Ratio for 3 consecutive years, with 0.01 the latest figure, recorded in Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.01, down 101.21% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01 (down 101.21% YoY), and the FY2025 annual result was 0.01, down 101.21% from the prior year.
• Equity Ratio was 0.01 for Q4 2025 at Medicus Pharma, up from 0.09 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.59 in Q4 2023 and troughed at 0.09 in Q3 2025.
• Average Equity Ratio over 3 years is 0.28, with a median of 0.33 recorded in 2025.
• Year-over-year, Equity Ratio slipped 5.45% in 2024 and tumbled 101.21% in 2025.
• Over 3 years, Equity Ratio stood at 0.59 in 2023, then retreated by 5.45% to 0.56 in 2024, then tumbled by 101.21% to 0.01 in 2025.
• Per Business Quant data, the three most recent Equity Ratio figures were 0.01 in Q4 2025, 0.09 in Q3 2025, and 0.27 in Q2 2025.